Fluvastatin prevents development of arterial stiffness in haemodialysis patients with type 2 diabetes mellitus

Nephrology Dialysis Transplantation

Volumn 17, Issue 8, 2002, Pages 1513-1517

  Ichihara, Atsuhiro ^a,b   Hayashi, Matsuhiko ^a   Ryuzaki, Munekazu ^b   Handa, Michiko ^b   Furukawa, Tomohiro ^c   Saruta, Takao ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KAWASAKI MUNICIPAL HOSPITAL   (Japan)

^c Kawasaki Clinic   (Japan)

Author keywords

Ankle brachial index; End stage renal disease; HMG CoA reductase inhibitor; Oxidized low density lipoprotein; Pulse wave velocity

Indexed keywords

C REACTIVE PROTEIN; FATTY ACID; FLUINDOSTATIN; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN; HYPOCHOLESTEROLEMIC AGENT; INDOLE DERIVATIVE; MONOUNSATURATED FATTY ACID; PHOSPHOLIPID; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTERY DISEASE; ARTICLE; BIOMECHANICS; BLOOD LEVEL; BLOOD PRESSURE; BODY MASS; BRACHIAL ARTERY; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FATTY ACID OXIDATION; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LONG TERM CARE; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PRIORITY JOURNAL; PULSE WAVE; RIGIDITY; BLOOD; BLOOD FLOW VELOCITY; COMPARATIVE STUDY; DIABETIC NEPHROPATHY; DRUG EFFECT; RENAL REPLACEMENT THERAPY; VASCULAR DISEASE;

ANTICHOLESTEREMIC AGENTS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FATTY ACIDS, MONOUNSATURATED; FATTY ACIDS, NONESTERIFIED; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INDOLES; PHOSPHOLIPIDS; PLACEBOS; RENAL DIALYSIS; TRIGLYCERIDES; VASCULAR DISEASES;

EID: 0035993292     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.8.1513     Document Type: Article

References (26)

1. Cardiovascular risk factors in chronic renal failure and hemodialysis populations
2. Diabetes and cardiovascular disease. The Framingham study
3. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
4. Profile of patients on RRT in Europe and death rates due to major causes of death groups
5. Excerpts from United States Renal Data System 1999 Annual Data Report
6. Report of the annual statistical survey of the Japanese Society for Dialysis Therapy in 1996
7. Impact of aortic stiffness on survival in end-stage renal disease
8. Diabetes mellitus, aortic stiffness and cardiovascular mortality in end-stage renal disease
9. Aortic and large artery compliance in end-stage renal failure
10. Non-invasive assessment of cardiovascular disease in diabetes mellitus
11. Arterial stiffness and cardiovascular risk factors in a population-based study
12. Fluvastatin for dyslipoproteinemia, with or without concomitant chronic renal insufficiency
13. Efficacy and safety of fluvastatin in patients with non-insulin-dependent diabetes mellitus and hyperlipidemia
14. The CHORUS (Cerivastatin in Heart Outcomes in Renal Disease: Understanding Survival) protocol: A double-blind, placebo-controlled trial in patients with ESRD
15. Long-term effects of pravastatin on plasma concentration of C-reactive protein
16. Effects of statin therapy on C-reactive protein levels
17. End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?
18. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure
19. Protective effect of chronic garlic intake on elastic properties of aorta in the elderly
20. Increased pulse wave velocity and shortened pulse wave transmission time in hypertension and aging
21. Clinical epidemiology of cardiovascular disease in chronic renal disease
22. Oxidative stress and inflammation in hemodialysis patients
23. Effect of fluvastatin on endothelium-dependent branchial artery vasodilation in patients after renal transplantation
24. Hydroxymethylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance
25. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase
26. Renal vascular function in hypercholesterolemia is preserved by chronic antioxidant supplementation